Skip to content
10-K

Annual Report

AGIOS PHARMACEUTICALS, INC. AGIO

0001439222-25-000009

← back to feed
Filed
Feb 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 7, 2025 57.3M sh
Cash And Equivalents FY 2024 · Dec 31, 2023 $88.21M
Current Liabilities FY 2024 · Dec 31, 2023 $67.96M
Total Liabilities FY 2024 · Dec 31, 2023 $126.1M
Current Assets FY 2024 · Dec 31, 2023 $833.84M
Total Assets FY 2024 · Dec 31, 2023 $937.12M
Shares Diluted FY 2024 · Dec 31, 2022 54.79M sh
Capex FY 2024 · Dec 31, 2022 $4.88M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$309.48M
Eps Diluted FY 2024 · Dec 31, 2022 −$4.23
Eps Basic FY 2024 · Dec 31, 2022 −$4.23
Sga Expense FY 2024 · Dec 31, 2022 $121.67M
Rd Expense FY 2024 · Dec 31, 2022 $279.91M
Net Income FY 2024 · Dec 31, 2022 −$231.8M
Operating Income FY 2024 · Dec 31, 2022 −$389.05M
Cost Of Revenue FY 2024 · Dec 31, 2022 $1.7M
Revenue FY 2024 · Dec 31, 2022 $14.24M
Stockholders Equity FY 2024 · Dec 31, 2021 $1.29B